NVCR Q2 2017 Earnings — NovoCure Limited Revenue & Financial Results | Market Cap Arena

NVCRNovoCure Limited

$1B

Q2 2017 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$38M+114.2% YoY

Gross Profit

$25M65.7% margin

Operating Income

-$16M-40.5% margin

Net Income

-$21M-55.2% margin

EPS (Diluted)

$-0.24

QoQ Revenue Growth

+10.0%

Cash Flow

Operating Cash Flow

-$6M

Free Cash Flow

-$7M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$257M

Total Liabilities

$139M

Stockholders' Equity

$118M

Cash & Equivalents

$80M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$38M	$18M	+114.2%
Gross Profit	$25M	$2M	+1375.1%
Operating Income	-$16M	-$37M	+58.3%
Net Income	-$21M	-$41M	+47.9%

Geographic Segments

UNITED STATES

$31M82%

E M E A

$7M18%

JAPAN

$118,0000%